香港股市 已收市

  • 恒指

    18,057.45
    +402.04 (+2.28%)
     

  • 國指

    6,262.61
    +163.35 (+2.68%)
     

  • 上證綜指

    3,132.43
    +47.73 (+1.55%)
     

  • 滬深300

    3,738.93
    +66.49 (+1.81%)
     

  • 美元

    7.8208
    +0.0008 (+0.01%)
     

  • 人民幣

    0.9326
    -0.0012 (-0.13%)
     

  • 道指

    34,065.54
    -4.88 (-0.01%)
     

  • 標普 500

    4,333.68
    +3.68 (+0.08%)
     

  • 納指

    13,251.83
    +27.85 (+0.21%)
     

  • 日圓

    0.0525
    -0.0003 (-0.53%)
     

  • 歐元

    8.3277
    -0.0068 (-0.08%)
     

  • 英鎊

    9.5740
    -0.0370 (-0.38%)
     

  • 紐約期油

    90.24
    +0.61 (+0.68%)
     

  • 金價

    1,944.50
    +4.90 (+0.25%)
     

  • Bitcoin

    26,610.97
    +3.97 (+0.01%)
     

  • CMC Crypto 200

    567.71
    -0.34 (-0.06%)
     

Penumbra Ramps Up Efforts To Launch Indigo Aspiration System In Japan

Vandana Singh
·1 分鐘文章

  • Penumbra Inc (NYSE: PEN) and Japan-based medical device manufacturer Asahi Intecc Co will collaborate to introduce Penumbra's Indigo Aspiration System into the Japanese market upon regulatory approval.

  • The Indigo Aspiration System can be used to remove emboli and thrombi from peripheral arterial and venous systems vessels and treat pulmonary embolism.

  • Indigo is a minimally-invasive device that enables blood flow restoration in cases such as acute limb ischemia and venous thrombus.

  • Related: Citing' Lightning Fast Growth,' Needham Upgrades This Vascular Device Company.

  • The newer generation device combines hypotube-based Indigo Aspiration Catheters with Lightning Intelligent Aspiration, a computer-aided clot detection technology that can differentiate between clot and blood, designed to reduce blood loss and the need for clot-dissolving drugs.

  • Penumbra's neurovascular thrombectomy and neurovascular and peripheral embolization devices will continue to be distributed by its long-time partner, Medico's Hirata.

  • Price Action: PEN shares are down 2.79% at $180.83 on the last check Thursday.

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.